Webinar | How Will Microbiome Reshape Anti-Aging Skin Care in 2026 Register Here

Enjosim

Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for biomacromolecule pharmaceuticals.
2021
51-100
Shanghai, Shanghai, China
  • Biopharma
  • GLP 1
  • Medical
  • Medical Device

Investment Funding

Last Funding Stage

Series A

Last Funding Date

09-09-2024

Startup Stage

Early Stage

Lead Investors

Lightspeed China Partners, Maotai Jianxin (Guizhou) Investment Fund, Jiayuan Capital, Yinman Venture Capital

Something missing or incorrect on this page? Help us enrich this information